Page last updated: 2024-08-23

etoposide and wr 1065

etoposide has been researched along with wr 1065 in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berthold, F; Fichtner, I; Fulda, S; Hero, B	1
Baruchel, S; Fouladi, M; Gammon, J; Grant, R; Greenberg, ML; Klein, J; Koren, G; Stempak, D	1
Bhavsar, T; Hahn, PJ; Hatoum, GF; Nevaldine, B; Phung, Q	1
Mann, K	1

Trials

2 trial(s) available for etoposide and wr 1065

Article	Year
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients. Medical and pediatric oncology, 2001, Volume: 36, Issue:1 Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays	2001
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma. Cancer, 2001, Aug-15, Volume: 92, Issue:4 Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure	2001

Article

Year

Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients.

Medical and pediatric oncology, 2001, Volume: 36, Issue:1

Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays

2001

Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma.

Cancer, 2001, Aug-15, Volume: 92, Issue:4

Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure

2001

Other Studies

2 other study(ies) available for etoposide and wr 1065

Article	Year
WR-1065, the active form of amifostine, protects HL-60 cells but not peripheral blood mononuclear cells from radiation and etoposide-induced apoptosis. International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Survival; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Leukocytes, Mononuclear; Mercaptoethylamines; Radiation-Protective Agents	2004
Methods for the study of redox-mediated changes in p53 structure and function. Methods in molecular biology (Clifton, N.J.), 2008, Volume: 476 Topics: Animals; Apoptosis; Cell Cycle; Cell Extracts; Diamide; DNA; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Etoposide; HCT116 Cells; Humans; Immunoblotting; Isotope Labeling; Mercaptoethylamines; Mice; Molecular Biology; Oxidation-Reduction; Protein Isoforms; Thioredoxins; Transfection; Tumor Suppressor Protein p53	2008

Article

Year

WR-1065, the active form of amifostine, protects HL-60 cells but not peripheral blood mononuclear cells from radiation and etoposide-induced apoptosis.

International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase Inhibitors; Cell Survival; Enzyme Inhibitors; Etoposide; HL-60 Cells; Humans; Leukocytes, Mononuclear; Mercaptoethylamines; Radiation-Protective Agents

2004

Methods for the study of redox-mediated changes in p53 structure and function.

Methods in molecular biology (Clifton, N.J.), 2008, Volume: 476

Topics: Animals; Apoptosis; Cell Cycle; Cell Extracts; Diamide; DNA; Electrophoresis, Polyacrylamide Gel; Electrophoretic Mobility Shift Assay; Etoposide; HCT116 Cells; Humans; Immunoblotting; Isotope Labeling; Mercaptoethylamines; Mice; Molecular Biology; Oxidation-Reduction; Protein Isoforms; Thioredoxins; Transfection; Tumor Suppressor Protein p53

2008